4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-23-049779
Chief Executive Officer sold 13,499 shares at an average $3.58 ($48,274)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2023-09-25 | Sale | −5,268 | $3.57 | $18,807 | 619,960 | D |
| Barrow Robert Chief Executive Officer | 2023-09-25 | Sale | −8,231 | $3.58 | $29,467 | 611,729 | D |
| Open-market sales · 13,499 sh · avg $3.58 · $48,274 | |||||||
Loading xslF345X05/ownership.xml…